Colchicine NDC 70710-1351

NDC codes

FDA NDC Directory

Product NDC (as listed)70710-1351Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70710-1351Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70710-1351-1	70710135101	1 BOTTLE in 1 CARTON (70710-1351-1) / 100 TABLET in 1 BOTTLEMarketed from Jun 12, 2019
70710-1351-3	70710135103	1 BOTTLE in 1 CARTON (70710-1351-3) / 30 TABLET in 1 BOTTLEMarketed from Jun 12, 2019
70710-1351-5	70710135105	1 BOTTLE in 1 CARTON (70710-1351-5) / 500 TABLET in 1 BOTTLEMarketed from Jun 12, 2019
70710-1351-9	70710135109	1 BOTTLE in 1 CARTON (70710-1351-9) / 90 TABLET in 1 BOTTLEMarketed from Jun 12, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Colchicine
Generic name (nonproprietary): colchicine
Active ingredients: Colchiceine — .6 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Zydus Pharmaceuticals USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211519
Marketing start: Jun 12, 2019
Listing expires: Dec 31, 2026
Identifiers: Product ID 70710-1351_cf874687-3377-4fd3-9616-6c1f74454ad3SPL ID cf874687-3377-4fd3-9616-6c1f74454ad3SPL set ID c8fd7034-5ca2-4a58-b303-7f78ffdf8d76UNII HJ30158L57

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470710135101 followed by a unit qualifier and the quantity

Package 70710-1351-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 4, 2022.

Indications (excerpt from the label)

Colchicine tablets are an alkaloid indicated for: Prophylaxis and treatment of gout flares in adults ( 1.1 ). Familial Mediterranean fever (FMF) in adults and children 4 years or older ( 1.2 ). 1.1 Gout Flares Colchicine tablets are indicated for prophylaxis and the treatment of acute gout flares. Prophylaxis of Gout Flares: Colchicine tablets are indicated for prophylaxis of gout flares. Treatment of Gout Flares: Colchicine tablets are indicated for treatment of acute gout flares when taken at the first sign of a flare. 1.2 Familial Mediterranean Fever (FMF) Colchicine tablets are indicated in adults and children four years or older for treatment of familial Mediterranean fever (FMF).…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211519

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211519
Product	Strength	Form · route	Labeler	Product NDC
Colchicine	Colchiceine .6 mg/1	TabletOral	Northstar Rx LLC.	16714-039
Colchicine	Colchiceine .3 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1590
Colchicine	Colchiceine .6 mg/1	TabletOral	A-S Medication Solutions	50090-7205
Colchicine	Colchiceine .6 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1396
Colchicine	Colchiceine .3 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1571